Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/43/34/06/433406de-8e13-9e4c-4048-704b39d63632/mza_8334669876383272529.png/600x600bb.jpg
Conversations in Drug Development
Boyds
23 episodes
1 week ago
Welcome to Conversations in Drug Development, brought to you by the team at Boyds. This podcast is for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development.
Show more...
Life Sciences
Health & Fitness,
Medicine,
Science
RSS
All content for Conversations in Drug Development is the property of Boyds and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Conversations in Drug Development, brought to you by the team at Boyds. This podcast is for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development.
Show more...
Life Sciences
Health & Fitness,
Medicine,
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/43/34/06/433406de-8e13-9e4c-4048-704b39d63632/mza_8334669876383272529.png/600x600bb.jpg
A Guide to Marketing Authorization Applications in Europe
Conversations in Drug Development
28 minutes 19 seconds
1 year ago
A Guide to Marketing Authorization Applications in Europe
In this episode, host Harriet Edwards is joined by Dr Katherine Bowen to explore the regulatory fundamentals for obtaining marketing authorisation in Europe, focusing on the centralised procedure.
Conversations in Drug Development
Welcome to Conversations in Drug Development, brought to you by the team at Boyds. This podcast is for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development.